Boudreau, E.A., Johnson, K.P., Jackman, A.R., Blancato, J., Huizing, M., Bendavid, C., Jones, M.P., Chandrasekharappa, S.C., Lewy, A.J., Smith, A.C.M. and Magenis, R.E. (2009) Review of Disrupted Sleep Patterns in Smith-Magenis Syndrome and Normal Melatonin Secretion in a Patient with an Atypical Interstitial 17p11.2 Deletion. American Journal of Medical Genetics, 149, 1382-1391.
http://dx.doi.org/10.1002/ajmg.a.32846

has been cited by the following article:

• TITLE: Melatonin Avoids Anatomofunctional Changes Associated to Aging in a Rat Model

  AUTHORS: Bertha Prieto Gómez, Cruz Reyes-Vázquez, Mireya Velázquez-Paniagua

  KEYWORDS: Rat, Melatonin, Hippocampus, Antioxidant, Aging

  JOURNAL NAME: Advances in Aging Research, Vol.3 No.4, September 18, 2014

  ABSTRACT: Melatonin is a hormone synthesized and released primarily by the pineal gland. Its secretion fol-lows a circadian rhythm with a peak overnight. Its secretion is initiated approximately to the three months of age and continues to rise during the childhood. Previous to the puberty there is a de-crease of melatonin secretion that continues until the old age. Melatonin has effects in the body and acts through at least four mechanisms: membrane receptors, orphan nuclear receptors, calmodulin and free radicals. It has been suggested that aging can be a consequence of the oxidation of cells that eventually become vulnerable to injury and die. This work reviews the antioxidant effects of melatonin in a rodent model, on the formation of free radicals, on the MAP2 protein expression and on the electrophysiology of the hippocampus at different ages. The results indicate that melatonin maintains in a “best” state to the experimental animals compared to controls. It suggests the use of melatonin as a therapy to prevent or delay the aging effects on the cells.